ly3298176 tirzepatide TFA (LY3298176 TFA, GIP and GLP-1 receptor agonist)-Therapeutic peptides drug benchmark for in-vivo/in-vitro study A Long-Term Study of Tirzepatide
Pay in 4 interest-free payments of $7.31 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22



32260-8/asset/49a02715-866b-43be-818a-fd87392a76a5/main.assets/gr2_lrg.jpg)























